MPO and inflammatory bowel disease: Likewise, oral administration of genistein decreased TNBS-stimulated chronic colitis by inhibition of COX-2 mRNA and protein expression together with the colonic myeloperoxidase (MPO) activity in rat that applies useful anti-inflammatory effects in the treatment of IBD (Seibel et al., 2009).